Based on a multivariate analysis model including adjuvant therapy and tumor grade in NMIBC, RFS was associated with HER2+, while OS was associated with age, T-stage, EP263, PD1, CD8, and Ki67 levels. This evidence concerns the gene CD8A and neoplasm.